Cochrane · systematic review · CD010531

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants

More, K, Athalye‐Jape, GK, Rao, SC, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
9
current version
GRADE rated
9
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 9 · 100%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: Neonates with PPHN
6 questions
OutcomeEffectEvidenceStatus / GRADE
Death from any cause prior to hospital discharge
RR 0.2 [0.02, 1.77]37 participantsLow
Percentage of infants that showed improvement in OI by at least 20% by the end of therapy
no estimate extracted39 participantsLow
Adverse neurological outcomes at six months of age
no estimate extracted37 participantsLow
Cerebral Palsy
no estimate extracted37 participantsLow
Deafness
no estimate extracted37 participantsLow
Need for ECMO prior to discharge
no estimate extracted21 participantsLow

Comparison

Population: Neonates with PPHN
1 question
OutcomeEffectEvidenceStatus / GRADE
Total duration of mechanical ventilation (days)
no estimate extracted37 participantsLow

Comparison

Population: Neonates with PPHN
2 questions
OutcomeEffectEvidenceStatus / GRADE
Duration of iNO therapy (days)
no estimate extracted21 participantsLow
Total duration of mechanical ventilation (days)
no estimate extracted21 participantsLow